ubmslateEN-logo-ubm

EN Mobile Logo

Search form

Topics:

News

News

How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?

Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.

Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?

Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.

A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.

The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.

Strength training can improve glycemic control among diabetics, but can it reduce rates of type 2 diabetes and cardiovascular disease?

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.